慢性肾脏病3～5期中西医结合临床路径效果分析

发布时间：2018-05-24 02:56

本文选题：慢性肾脏病 + 临床路径　；参考：《实用医学杂志》2012年06期

【摘要】：目的:探讨慢性肾脏病3～5期中西医结合临床路径实施效果。方法:采用非同期历史对照,观察路径组和回顾性病案组住院天数、住院费用、肾功能指标情况。结果:经临床路径规范管理后,患者的住院天数较回顾性病案组(非路径组)缩短(P=0.008),路径组总费用较高于回顾性病案组总费用(P=0.100),其中中药费(P0.05)、中成药(P0.05)、化验费(P0.05)较回顾性病案组升高。西药费(P0.05)、检查费(P0.05)较回顾性病案组降低。肾功能指标两组均有改善,组间比较无差异(P0.05)。结论:慢性肾脏病3～5期中西医结合临床路径能缩短住院天数,有助于医疗费用的合理支出。其对于肾功能指标的改善仍有待长期的随访研究和开展平行对照研究进一步证实。
[Abstract]:Objective: to investigate the effect of clinical pathway of combined traditional Chinese and western medicine in stage 3 of chronic kidney disease. Methods: the days of hospitalization, the cost of hospitalization and the indexes of renal function were observed in path-group and retrospect STD group. Results: after the standardized management of clinical pathway, The hospitalization days of the patients were shorter than those of the retrospective STD cases (non-paw group), and the total cost of the paw group was higher than that of the retrospect STD cases group (P 0.100), in which the drug cost was P0.05, the traditional Chinese patent medicine P0.05, and the test fee P0.05) higher than that in the retrospective STD case group. The cost of western medicine was lower than that of retrospective cases of venereal diseases (P 0.05, P 0.05). The indexes of renal function were improved in both groups, and there was no difference between the two groups (P 0.05). Conclusion: the clinical pathway of integrated traditional Chinese and western medicine in stage 3 of chronic kidney disease can shorten the days of hospitalization and contribute to the reasonable expenditure of medical expenses. The improvement of renal function should be confirmed by long-term follow-up study and parallel control study.
【作者单位】：广东省中医院肾内科;
【基金】：国家中医药管理局公益性行业科研专项(编号:200707004)
【分类号】：R692

【共引文献】